Categories:Corporate

PowderJect Pharmaceuticals completes vendor placing of shares and acquisition of SBL Vaccin from Active Biotech for £35.5m, 75 per cent of which came from the placing.

  • Print
  • Comment

Have your say

Mandatory Required Fields

Mandatory

Comments that are in breach or potential breach of our terms and conditions in particular clause 8, may not be published or, if published, may subsequently be taken down. In addition we may remove any comment where a complaint is made in respect of it. These actions are at our sole discretion.

  • Print
  • Comment